Abstract
Even though circular RNAs (circRNAs), a class of non-coding endogenous RNA, play a crucial role in the progression of osteosarcoma (OS), the specific function of hsa_circ_0000028 (circUSP48) remains unclear. This study aims to elucidate the mechanism by which circUSP48 regulates OS. We employed qRT-PCR and western blot techniques to quantify circDOCK1, miR-186, and DNMT3A levels. Cell proliferation was assessed using the cell counting kit-8 (CCK-8), 5-Ethynyl-20-deoxyuridine (EdU) assay, and colony formation assay. Cell migration and invasion were evaluated through Transwell and cell scratch assays. Furthermore, we performed dual-luciferase reporter, RIP, and RNA pull-down assays to investigate the association between circUSP48, miR-365, and CYR61. In addition, an in vivo xenograft model was utilized to assess the functional role of circUSP48. High levels of circUSP48 and CYR61 were observed in OS tissues and cells, while miR-365 levels were low. Knockdown of circUSP48 suppressed the multiplication, motility, and invasion of OS cells, thereby reducing carcinoma growth. Moreover, inhibition of miR-365 reversed the OS cell-suppressive effect caused by circUSP48 knockdown through direct interaction with circUSP48. Additionally, circUSP48 upregulated the expression of CYR61 by sponging miR-365. The findings suggest that circUSP48 promotes malignant behavior in OS by regulating the expression of CYR61 through miR-365, making it a potential therapeutic target for OS.
Similar content being viewed by others
Data availability
The data are available from the corresponding author upon request.
References
Anderson ME (2016) Update on Survival in Osteosarcoma. Orthop Clin North Am 47:283–292. https://doi.org/10.1016/j.ocl.2015.08.022
Bose R, Ain R (2018) Regulation of Transcription by Circular RNAs. Adv Exp Med Biol 1087:81–94. https://doi.org/10.1007/978-981-13-1426-1_7
Duan Z, Wei S, Liu Y (2021) Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p. J Bioenerg Biomembr 53:223–233. https://doi.org/10.1007/s10863-021-09876-6
El-Husseiny AA, Abdelmaksoud NM, Mageed SSA, Salman A, Zaki MB, El-Mahdy HA, Ismail A, Abd-Elmawla MA, El-Husseiny HM, Abulsoud AI, Elshaer SS, Elsakka EGE, Fathi D, El-Dakroury WA, Doghish AS (2023) miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance. Pathol, Res Practice 248:154590. https://doi.org/10.1016/j.prp.2023.154590
Ferguson JL, Turner SP (2018) Bone Cancer: Diagnosis and Treatment Principles. Am Fam Physician 98:205–213
Fromigue O, Hamidouche Z, Vaudin P, Lecanda F, Patino A, Barbry P, Mari B, Marie PJ (2011) CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis. J Bone Min Res 26:1533–1542. https://doi.org/10.1002/jbmr.343
Ghafouri-Fard S, Khoshbakht T, Hussen BM, Sarfaraz S, Taheri M, Ayatollahi SA (2022) Circ_CDR1as: A circular RNA with roles in the carcinogenesis. Pathol, Res Practice 236:153968. https://doi.org/10.1016/j.prp.2022.153968
Habel N, Stefanovska B, Carène D, Patiño-Garcia A, Lecanda F, Fromigué O (2019) CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process. BMC Cancer 19:62. https://doi.org/10.1186/s12885-019-5282-4
Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R (2018) Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther 18:39–50. https://doi.org/10.1080/14737140.2018.1413939
Hill M, Tran N (2021) miRNA interplay: mechanisms and consequences in cancer. Disease Models & Mechanisms 14. https://doi.org/10.1242/dmm.047662
Isakoff MS, Bielack SS, Meltzer P, Gorlick R (2015) Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol 33:3029–3035. https://doi.org/10.1200/jco.2014.59.4895
Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675–691. https://doi.org/10.1038/s41576-019-0158-7
Li J, Sun D, Pu W, Wang J, Peng Y (2020) Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance. Trends in Cancer 6:319–336. https://doi.org/10.1016/j.trecan.2020.01.012
Li S, Liu F, Zheng K, Wang W, Qiu E, Pei Y, Wang S, Zhang J, Zhang X (2021) CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Mol Cancer 20:161. https://doi.org/10.1186/s12943-021-01453-0
Li F, Yin YK, Zhang JT, Gong HP, Hao XD (2022a) Role of circular RNAs in retinoblastoma. Funct Integr Genomics 23:13. https://doi.org/10.1007/s10142-022-00942-9
Li S, Zhang Y, He Z, Xu Q, Li C, Xu B (2022c) Knockdown of circMYOF inhibits cell growth, metastasis, and glycolysis through miR-145-5p/OTX1 regulatory axis in laryngeal squamous cell carcinoma. Funct Integr Genomics 22:1–13. https://doi.org/10.1007/s10142-022-00862-8
Li L, Zhan M, Li M (2022b) Circular RNA circ_0130438 suppresses TNF-α-induced proliferation, migration, invasion and inflammation in human fibroblast-like MH7A synoviocytes by regulating miR-130a-3p/KLF9 axis. Transplant Immunol 101588. https://doi.org/10.1016/j.trim.2022.101588
Liu Y, Zhang F, Zhang Z, Wang D, Cui B, Zeng F, Huang L, Zhang Q, Sun Q (2017) High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma. Pathol Res Pract 213:895–899. https://doi.org/10.1016/j.prp.2017.06.004
Liu W, Long Q, Zhang W, Zeng D, Hu B, Liu S, Chen L (2021) miRNA-221–3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis. Aging 13:19760–19775. https://doi.org/10.18632/aging.203388
Liu QW, He Y, Xu WW (2022) Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer. Exp Mol Med. https://doi.org/10.1038/s12276-022-00744-w
Lou J, Zhang H, Xu J, Ren T, Huang Y, Tang X, Guo W (2022) circUSP34 accelerates osteosarcoma malignant progression by sponging miR-16-5p. Cancer Sci 113:120–131. https://doi.org/10.1111/cas.15147
Mao X, Guo S, Gao L, Li G (2021) Circ-XPR1 promotes osteosarcoma proliferation through regulating the miR-214-5p/DDX5 axis. Hum Cell 34:122–131. https://doi.org/10.1007/s13577-020-00412-z
Mishra S, Yadav T, Rani V (2016) Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol 98:12–23. https://doi.org/10.1016/j.critrevonc.2015.10.003
Qin G, Wu X (2021) Circular RNA hsa_circ_0032463 Acts as the Tumor Promoter in Osteosarcoma by Regulating the MicroRNA 498/LEF1 Axis. Mol Cellular Biol 41:e0010021. https://doi.org/10.1128/mcb.00100-21
Sahin Y, Altan Z, Arman K, Bozgeyik E, Koruk Ozer M, Arslan A (2017) Inhibition of miR-664a interferes with the migration of osteosarcoma cells via modulation of MEG3. Biochem Biophys Res Commun 490:1100–1105. https://doi.org/10.1016/j.bbrc.2017.06.174
Salzman J (2016) Circular RNA Expression: Its Potential Regulation and Function. Trends in Genetics : TIG 32:309–316. https://doi.org/10.1016/j.tig.2016.03.002
Shen JF, Ge JF, Zheng SY, Jiang D (2021) Integrative analysis of differential circular RNA and long non-coding RNA profiles and associated competing endogenous RNA networks in esophageal squamous cell carcinoma. Funct Integr Genomics 21:125–138. https://doi.org/10.1007/s10142-020-00765-6
Shi Y, Tian Y, Sun X, Qiu Y, Zhao Y (2022) Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression. Front Oncol 12:889583. https://doi.org/10.3389/fonc.2022.889583
Shoaib Z, Fan TM, Irudayaraj JMK (2022) Osteosarcoma mechanobiology and therapeutic targets. Br J Pharmacol 179:201–217. https://doi.org/10.1111/bph.15713
Siegel HJ, Pressey JG (2008) Current concepts on the surgical and medical management of osteosarcoma. Expert Rev Anticancer Ther 8:1257–1269. https://doi.org/10.1586/14737140.8.8.1257
Simpson E, Brown HL (2018) Understanding Osteosarcomas Jaapa 31:15–19. https://doi.org/10.1097/01.JAA.0000541477.24116.8d
Todosenko N, Khlusov I, Yurova K, Khaziakhmatova O, Litvinova L (2023) Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. Int J Mol Sci 24. https://doi.org/10.3390/ijms24108993
Vishnoi A, Rani S (2017) MiRNA Biogenesis and Regulation of Diseases: An Overview. Methods Mol Biol 1509:1–10. https://doi.org/10.1007/978-1-4939-6524-3_1
Wang L, Li B, Yi X, Xiao X, Zheng Q, Ma L (2021a) Circ_SMAD4 promotes gastric carcinogenesis by activating wnt/β-catenin pathway. Cell proliferation 54:e12981. https://doi.org/10.1111/cpr.12981
Wang Y, Wo Y, Lu T, Sun X, Liu A, Dong Y, Du W, Su W, Huang Z, Jiao W (2021b) Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140–3p to activate E2F7 expression. Transl Lung Cancer Res 10:57–70. https://doi.org/10.21037/tlcr-20-1062
Wang S, Li W, Yang L, Yuan J, Wang L, Li N, Zhao H (2022a) CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway. Funct Integr Genomics 22:891–903. https://doi.org/10.1007/s10142-022-00865-5
Wang S, Liu D, Wei H, Hua Y, Shi G, Qiao J (2022b) The hsa_circRNA_102049 mediates the sorafenib sensitivity of hepatocellular carcinoma cells by regulating Reelin gene expression. Bioengineered 13:2272–2284. https://doi.org/10.1080/21655979.2021.2024332
Wang Z, Sun A, Yan A, Yao J, Huang H, Gao Z, Han T, Gu J, Li N, Wu H, Li K (2022c) Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation. Mol Cancer 21:92. https://doi.org/10.1186/s12943-022-01570-4
Whelan JS, Davis LE (2018) Osteosarcoma, Chondrosarcoma, and Chordoma. J Clin Oncol 36:188–193. https://doi.org/10.1200/jco.2017.75.1743
Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, Li Y, Li X, Li G, Zeng Z, Xiong W (2020) Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer 19:22. https://doi.org/10.1186/s12943-020-1147-3
Xiao X, Wang W, Wang Z (2014) The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatr Drugs 16:503–512. https://doi.org/10.1007/s40272-014-0095-z
Yan LR, Ding HX, Shen SX, Lu XD, Yuan Y, Xu Q (2021) Pepsinogen C expression-related lncRNA/circRNA/mRNA profile and its co-mediated ceRNA network in gastric cancer. Funct Integr Genomics 21:605–618. https://doi.org/10.1007/s10142-021-00803-x
Zhang C, Zhou H, Yuan K, Xie R, Chen C (2020) Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593–3p/ZEB2 pathway. Aging 12:10488–10496. https://doi.org/10.18632/aging.103273
Zhang C, Na N, Liu L, Qiu Y (2021) CircRNA hsa_circ_0005909 Promotes Cell Proliferation of Osteosarcoma Cells by Targeting miR-338-3p/HMGA1 Axis. Cancer Manag Res 13:795–803. https://doi.org/10.2147/cmar.S285118
Zhao X, Wu Q, Gong X, Liu J, Ma Y (2021) Osteosarcoma: a review of current and future therapeutic approaches. Biomed Eng Online 20:24. https://doi.org/10.1186/s12938-021-00860-0
Zheng S, Jiang F, Ge D, Tang J, Chen H, Yang J, Yao Y, Yan J, Qiu J, Yin Z, Ni Y, Zhao L, Chen X, Li H, Yang L (2019) LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother 112:108695. https://doi.org/10.1016/j.biopha.2019.108695
Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer 19:172. https://doi.org/10.1186/s12943-020-01286-3
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
Bo Yang contributed to the conception and design. Shunguang Chen and Yan Xu carried out the experiment and wrote the paper.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The Ethics Committee of Renmin Hospital of Wuhan University approved investigations involving human samples and animal experiments. Written informed consents were obtained from all participants.
Competing interests
The authors declared there were no potential conflicts.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, S., Xu, Y. & Yang, B. CircUSP48 promotes malignant behavior by regulating CYR61 via miR-365 in osteosarcoma. Funct Integr Genomics 23, 270 (2023). https://doi.org/10.1007/s10142-023-01197-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10142-023-01197-8